No consensus strategies exist for prognosticating metastatic castration-resistant prostate
cancer (mCRPC). Circulating tumor DNA fraction (ctDNA%) is increasingly reported by …

Cardiac troponin is extensively used as a biomarker in modern medicine due to its
diagnostic capability for myocardial injury, as well as its predictive and prognostic value for …

Purpose This study aimed to investigate the impact of sprint interval training (SIT) on both
the acute and 3-week modulations of cell-free DNA (cfDNA), as well as its association with …

Angiosarcoma is a rare and aggressive type of soft-tissue sarcoma with high propensity to
metastasize. For patients with metastatic angiosarcoma, prognosis is dismal and treatment …

Cardiac troponin is integral in the diagnosis of myocardial injury and infarction. The Fourth
Universal Definition recommends a classification by aetiology, in order to encourage …

Myocardial scarring is an important substrate of life-threatening arrhythmias because it can
give rise to re-entrant ventricular tachycardia (VT). Clinically, myocardial scar is usually …

Cell-free DNA (cfDNA) is increasingly recognized as a promising biomarker candidate for
disease monitoring. However, its utility in neurodegenerative diseases, like amyotrophic …

Background Primary human neutrophils play a pivotal role in innate immunity, mainly
through the formation of neutrophil extracellular traps (NETs) in a process known as …

Purpose Exercise-induced cfDNA has been studied in response to various types of exercise.
Its correlation with exercise intensity and duration has been observed consistently. However …

Cell-free DNA (cfDNA) is continuously shed by all cells in the body, but the regulation of this
process and its physiological functions are still largely unknown. Previous studies have …